{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:04:35Z","timestamp":1778825075401,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0384-x","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T05:32:43Z","timestamp":1427607163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma"],"prefix":"10.1186","volume":"10","author":[{"given":"Indira","family":"Madani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony J","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Trnkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien C","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00172765","volume":"13","author":"R Miralbell","year":"1992","unstructured":"Miralbell R, Linggood RM, De Las Monte S, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neuro-Oncol. 1992;13:157\u201364.","journal-title":"J Neuro-Oncol"},{"key":"384_CR2","first-page":"176","volume-title":"Pathology and genetics of tumours of the nervous system: World Health Organisation classification of tumours","author":"DN Louis","year":"2000","unstructured":"Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumours of the nervous system: World Health Organisation classification of tumours. Lyon: IARC Press; 2000. p. 176\u201384."},{"key":"384_CR3","doi-asserted-by":"crossref","unstructured":"Weber DC, Lovblad KO, Rogers L. New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol. 2010;23(6):563-70.","DOI":"10.1097\/WCO.0b013e328340441e"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1227\/00006123-199207000-00002","volume":"31","author":"M Kallio","year":"1992","unstructured":"Kallio M, Sankila R, Hakulinen T, J\u00e4\u00e4skel\u00e4inen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31:2\u201312.","journal-title":"Neurosurgery"},{"key":"384_CR5","first-page":"1029","volume":"49","author":"SL Stafford","year":"2001","unstructured":"Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery. 2001;49:1029\u201337.","journal-title":"Neurosurgery"},{"key":"384_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","volume":"65","author":"S Milker-Zabel","year":"2006","unstructured":"Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65:222\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0360-3016(02)02823-7","volume":"53","author":"NW Uy","year":"2002","unstructured":"Uy NW, Woo SY, Teh BS, Mai WY, Carpenter LS, Chiu JK, et al. Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys. 2002;53:1265\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ijrobp.2006.12.073","volume":"68","author":"S Milker-Zabel","year":"2007","unstructured":"Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys. 2007;68:858\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ijrobp.2011.08.027","volume":"83","author":"DC Weber","year":"2012","unstructured":"Weber DC, Schneider R, Goitein G, Koch T, Ares C, Geismar JH, et al. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys. 2012;83:865\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1006434124794","volume":"48","author":"EB Hug","year":"2000","unstructured":"Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000;48:151\u201360.","journal-title":"J Neurooncol"},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.10.053","volume":"75","author":"C Boskos","year":"2009","unstructured":"Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys. 2009;75:399\u2013406.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7785\/tcrt.2012.500267","volume":"11","author":"AW Chan","year":"2012","unstructured":"Chan AW, Bernstein KD, Adams JA, Parambi RJ, Loeffler JS. Dose escalation with proton radiation therapy for high-grade meningiomas. Technol Cancer Res Treat. 2012;11:607\u201314.","journal-title":"Technol Cancer Res Treat"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3171\/JNS-07\/08\/0325","volume":"107","author":"A Kollov\u00e1","year":"2007","unstructured":"Kollov\u00e1 A, Lisc\u00e1k R, Novotn\u00fd Jr J, Vladyka V, Simonova G, Janouskova L. Gamma Knife surgery for benign meningioma. J Neurosurg. 2007;107:325\u201336.","journal-title":"J Neurosurg"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","volume":"47","author":"CC Ling","year":"2000","unstructured":"Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1470-2045(05)01737-7","volume":"6","author":"SM Bentzen","year":"2005","unstructured":"Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6:112\u20137.","journal-title":"Lancet Oncol"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","volume":"76","author":"A Dutour","year":"1998","unstructured":"Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, et al. Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer. 1998;76:620\u20137.","journal-title":"Int J Cancer"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","volume":"66","author":"S Arena","year":"2004","unstructured":"Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, et al. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol. 2004;66:155\u201366.","journal-title":"J Neurooncol"},{"key":"384_CR18","first-page":"1053","volume":"42","author":"M Henze","year":"2001","unstructured":"Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, et al. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med. 2001;42:1053\u20136.","journal-title":"J Nucl Med"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","volume":"39","author":"A Afshar-Oromieh","year":"2012","unstructured":"Afshar-Oromieh A, Giesel FL, Linhart HG, Haberkorn U, Haufe S, Combs SE, et al. Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET\/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging. 2012;39:1409\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1748-717X-4-56","volume":"4","author":"B Gehler","year":"2009","unstructured":"Gehler B, Paulsen F, Oks\u00fcz MO, Hauser TK, Eschmann SM, Bares R, et al. [68Ga]-DOTATOC-PET\/CT for meningioma IMRT treatment planning. Radiat Oncol. 2009;4:56.","journal-title":"Radiat Oncol"},{"key":"384_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","volume":"85","author":"R Graf","year":"2013","unstructured":"Graf R, Nyuyki F, Steffen IG, Michel R, Fahdt D, Wust P, et al. Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85:68\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR22","first-page":"763","volume":"46","author":"M Henze","year":"2005","unstructured":"Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J, Strauss LG, Doll J, et al. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med. 2005;46:763\u20139.","journal-title":"J Nucl Med"},{"key":"384_CR23","first-page":"485","volume":"20","author":"V Barresi","year":"2008","unstructured":"Barresi V, Alafaci C, Salpietro F, Tuccari G. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? Oncol Rep. 2008;20:485\u201392.","journal-title":"Oncol Rep"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-007-0251-4","volume":"114","author":"V Barresi","year":"2007","unstructured":"Barresi V, Cerasoli S, Vitarelli E, Tuccari G. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol. 2007;114:147\u201356.","journal-title":"Acta Neuropathol"},{"key":"384_CR25","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. \"Malignancy\" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999;85:2046\u201356.","journal-title":"Cancer"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0360-3016(99)00438-1","volume":"46","author":"R Mohan","year":"2000","unstructured":"Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000;46:619\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00259-008-0943-6","volume":"36","author":"H Vees","year":"2009","unstructured":"Vees H, Senthamizhchelvan S, Miralbell R, Weber DC, Ratib O, Zaidi H. Assessment of various strategies for 18\u00a0F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging. 2009;36:182\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1118\/1.597522","volume":"22","author":"E Pedroni","year":"1995","unstructured":"Pedroni E, Bacher R, Blattmann H, Bohringer T, Coray A, Lomax A, et al. The 200-MeV proton therapy project at the Paul Scherrer Institute: Conceptual design and practical realization. Med Phys. 1995;22:37\u201353.","journal-title":"Med Phys"},{"key":"384_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF01214833","volume":"31","author":"S Scheib","year":"1992","unstructured":"Scheib S, Pedroni E. Dose calculation and optimization for 3D conformal voxel scanning. Radiat Environ Biophys. 1992;31:251\u20136.","journal-title":"Radiat Environ Biophys"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1088\/0031-9155\/44\/1\/004","volume":"44","author":"B Schaffner","year":"1999","unstructured":"Schaffner B, Pedroni E, Lomax A. Dose calculation models for proton treatment planning using a dynamic beam delivery system: An attempt to include density heterogeneity effects in the analytical dose calculation. Phys Med Biol. 1999;44:27\u201341.","journal-title":"Phys Med Biol"},{"key":"384_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1118\/1.596887","volume":"19","author":"PL Petti","year":"1992","unstructured":"Petti PL. Differential-pencil-beam dose calculations for charged particles. Med Phys. 1992;19:137\u201349.","journal-title":"Med Phys"},{"key":"384_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1088\/0031-9155\/44\/1\/014","volume":"44","author":"A Lomax","year":"1999","unstructured":"Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44:185\u2013205.","journal-title":"Phys Med Biol"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1748-717X-8-23","volume":"8","author":"M Coskun","year":"2013","unstructured":"Coskun M, Straube W, Hurkmans CW, Melidis C, de Haan PF, Villa S, et al. Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews. Radiat Oncol. 2013;8:23.","journal-title":"Radiat Oncol"},{"key":"384_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.radonc.2014.05.018","volume":"111","author":"U Mock","year":"2014","unstructured":"Mock U, Georg D, Solkner L, Suppan C, Vatnitsky SM, Flechl B, et al. Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option. Radiother Oncol. 2014;111:451\u20136.","journal-title":"Radiother Oncol"},{"key":"384_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3109\/0284186X.2013.762996","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs SE, Welzel T, Habermehl D, Rieken S, Dittmar JO, Kessel K, et al. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET. Acta Oncol. 2013;52:514\u201320.","journal-title":"Acta Oncol"},{"key":"384_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1748-717X-9-202","volume":"9","author":"XR Zhu","year":"2014","unstructured":"Zhu XR, Poenisch F, Li H, Sahoo N, Wu RY, Li X, et al. A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol. 2014;9:202.","journal-title":"Radiat Oncol"},{"key":"384_CR37","unstructured":"Lehde A. Initial clinical evaluation of PSIPLAN2 and Gantry2: a planning comparison study in proton therapy. Master thesis. Bern University of Applied Sceince. 2013"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-015-0384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0384-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:41:58Z","timestamp":1553625718000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-015-0384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0384-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"19 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}